2023
DOI: 10.3390/ijms241512474
|View full text |Cite
|
Sign up to set email alerts
|

New Clinical and Immunofluorescence Data of Collagen VI-Related Myopathy: A Single Center Cohort of 69 Patients

Luciano Merlini,
Patrizia Sabatelli,
Francesca Gualandi
et al.

Abstract: Pathogenetic mechanism recognition and proof-of-concept clinical trials were performed in our patients affected by collagen VI-related myopathies. This study, which included 69 patients, aimed to identify innovative clinical data to better design future trials. Among the patients, 33 had Bethlem myopathy (BM), 24 had Ullrich congenital muscular dystrophy (UCMD), 7 had an intermediate phenotype (INTM), and five had myosclerosis myopathy (MM). We obtained data on muscle strength, the degree of contracture, immun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 76 publications
0
6
0
Order By: Relevance
“…Merlini et al conducted a cohort study in patients affected by collagen VI-related myopathies, providing clinical and genetic information and presenting quantitative data on muscle strength and contractures that can be valuable in clinical trials [17]. Their results show that respiratory failure can be a part of the clinical spectrum even in ambulatory patients, confirming the relationship between FVC and the three common collagen VI-related myopathies phenotypes acknowledged in previous studies [20,21].…”
Section: Discussionmentioning
confidence: 75%
See 1 more Smart Citation
“…Merlini et al conducted a cohort study in patients affected by collagen VI-related myopathies, providing clinical and genetic information and presenting quantitative data on muscle strength and contractures that can be valuable in clinical trials [17]. Their results show that respiratory failure can be a part of the clinical spectrum even in ambulatory patients, confirming the relationship between FVC and the three common collagen VI-related myopathies phenotypes acknowledged in previous studies [20,21].…”
Section: Discussionmentioning
confidence: 75%
“…Highly developed research centers have contributed to the discovery of the connection between mitochondrial dysfunction [17,18] and defective autophagy [17,19] in the pathogenesis of collagen VI-related myopathies.…”
Section: Discussionmentioning
confidence: 99%
“…Tendon biopsies of four unaffected donors and three genetically characterized UCMD patients [ 7 ] were used for the study. Biopsies were isolated from the pedidium tendons of two UCMD patients carrying a heterozygous c.896G>A mutation in COL6A1 (p.Gly299Glu, UCMD1), and a homozygous c.2572C>T mutation in COL6A2 (p.Gln858X, UCMD2), respectively, and from the Achilles tendon of one UCMD patient with a heterozygous c.850G>A mutation in COL6A1 (p.Gly284Arg, UCMD3).…”
Section: Methodsmentioning
confidence: 99%
“…In addition to variable muscle weakness, patients affected by COL6-RM display different degrees of axial and proximal joint contractures together with distal joint hypermobility, which worsen motor capability and deeply affect patients’ quality of life [ 7 ]. Therefore, understanding the mechanisms underlying the onset of contractures is crucial for the development of effective therapeutic strategies in COL6-RM.…”
Section: Introductionmentioning
confidence: 99%
“…Three patients were included in a report of a cohort of patients with COL6-RD in Italy. 21 Phenotypic data on the clinical presentation of patients with a phenotype of UCMD due to causative variants in the COL6 genes other than the COL6A1 c.930+189C>T variant were evaluated to serve as a comparison cohort to the COL6A1 c.930+189C>T specific cohort. Seventeen patients with UCMD, 12 females and 5 males evaluated at the National Institutes of Health (NIH) were included in this comparison cohort (Supplementary Table 1).…”
Section: Clinical Presentationmentioning
confidence: 99%